drugset / Trial / NCT00930631

Study of [3H] BMS747158 in Healthy Male Subjects

NCT00930631 ↗

Phase 1 Completed 7 enrolled Lantheus Medical Imaging
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this clinical study is to assess the safety, extent and route of \[3H\] BMS747158 radioactivity eliminated (mass balance) in urine and feces of healthy male subjects. The safety of \[3H\] BMS747158 administration will also be assessed, as well as pharmacokinetics of \[3H\] BMS747158 and metabolite identification.

Timeline

Start
2009-06
Primary completion
2009-07
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS747158 Diagnostic / imaging agent 100 unknown Intravenous